U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
182671182671Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of EpirubicinTerminatedNo Results AvailableBreast CancerDrug: Epirubicinhttps://ClinicalTrials.gov/show/NCT00162812
182672182672Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human ObesityCompletedNo Results AvailableInsulin ResistanceDrug: Triflusal (DCI)https://ClinicalTrials.gov/show/NCT00162799
182673182673Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving PerformanceTerminatedNo Results AvailableHealthyDrug: Rupatadine|Drug: Hydroxyzine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00162786
182674182674Effect of Anti-IgE in Non-Allergic AsthmaRecruitingNo Results AvailableAsthmaDrug: omalizumabhttps://ClinicalTrials.gov/show/NCT00162773
182675182675Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNo Results AvailableIdiopathic Pulmonary Fibrosis (IPF)Drug: Thalidomidehttps://ClinicalTrials.gov/show/NCT00162760
182676182676Topical Therapy for Prevention of Infections in Preterm InfantsCompletedNo Results AvailableSkin DiseasesDrug: Aquaphor|Drug: Sunflower Seed Oilhttps://ClinicalTrials.gov/show/NCT00162747
182677182677Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNo Results AvailableChronic Hepatitis CDrug: Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wkshttps://ClinicalTrials.gov/show/NCT00162734
182678182678The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine SarcomasRecruitingNo Results AvailableUterine SarcomaDrug: doxorubicin, ifosfamide, cisplatinhttps://ClinicalTrials.gov/show/NCT00162721
182679182679Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCCCompletedNo Results AvailableOropharynx Cancer|Oral Cancer|Hypopharynx Cancer|Larynx CancerProcedure: Radiotherapy 62-64 Gy in 5 W (31-32 f. of 2 Gy BID)|Procedure: Radiotherapy 62-64 Gy in 22-23 D (31-32 f of 2 Gy BID)|Drug: CDDP, 5 Fuhttps://ClinicalTrials.gov/show/NCT00162708
182680182680Rhabdomyosarcoma and Malignant Soft Tissue Tumours of ChildhoodTerminatedNo Results AvailableRhabdomyosarcoma|Malignant Soft TissueDrug: Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposidehttps://ClinicalTrials.gov/show/NCT00162695
182681182681Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in ThailandCompletedNo Results AvailableHIV InfectionsProcedure: Antiretroviral Drug Combination Switching Criteria|Procedure: Antiretroviral Drug Combination Switching Criteriahttps://ClinicalTrials.gov/show/NCT00162682
182682182682Bevacizumab in Advanced Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular CarcinomaDrug: bevacizumabhttps://ClinicalTrials.gov/show/NCT00162669
182683182683Treatment of Mature B-cell Lymphoma/LeukaemiaCompletedNo Results AvailableB-Cell LymphomaDrug: half cyclophosphamide|Drug: without COPADM3|Drug: mini CYVE, without 3 maintenance courses|Drug: LMB B|Drug: LMB Chttps://ClinicalTrials.gov/show/NCT00162656
182684182684PI Vs. NNRTI Based Therapy for HIV Advanced DiseaseRecruitingNo Results AvailableAcquired Immunodeficiency SyndromeDrug: zidovudine+lamivudine+lopinavir/ritonavir|Drug: zidovudine + lamivudine + efavirenzhttps://ClinicalTrials.gov/show/NCT00162643
182685182685Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute PhaseCompletedNo Results AvailableHip FractureProcedure: Fascia Iliaca Compartment Blockadehttps://ClinicalTrials.gov/show/NCT00162630
182686182686The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture SurgeryActive, not recruitingNo Results AvailableHip FractureDrug: Red blood cell transfusionhttps://ClinicalTrials.gov/show/NCT00162617
182687182687Prophylactic Antibiotic Treatment During Vaginal RepairRecruitingNo Results AvailableUterine Prolapse|Cystocele|Rectocele|EnteroceleDrug: Cefuroximehttps://ClinicalTrials.gov/show/NCT00162604
182688182688Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of RemifentanylRecruitingNo Results AvailablePainDrug: remifentanylhttps://ClinicalTrials.gov/show/NCT00162591
182689182689Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal MeningitisCompletedNo Results AvailablePneumococcal Meningitishttps://ClinicalTrials.gov/show/NCT00162578
182690182690Beta-Blocker Continuation Versus Interruption in Heart Failure WorseningCompletedNo Results AvailableHeart Failure, CongestiveDrug: beta-blocker treatmenthttps://ClinicalTrials.gov/show/NCT00162565
182691182691Clinical Trial of Pentoxifylline in Patient With CirrhosisCompletedNo Results AvailableCirrhosis|Liver FailureDrug: pentoxifylline|Drug: PLACEBOhttps://ClinicalTrials.gov/show/NCT00162552
182692182692Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid DimensionCompletedNo Results AvailableDeficiency DiseaseOther: echographyhttps://ClinicalTrials.gov/show/NCT00162539
182693182693Tocopherol is a Novel Treatment for Cancer Related MucositisWithdrawnNo Results AvailableOral MucositisDrug: Tocopherolhttps://ClinicalTrials.gov/show/NCT00162526
182694182694Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid LeukemiaWithdrawnNo Results AvailableChronic Myeloid LeukemiaBiological: Allogeneic tumor cell vaccinehttps://ClinicalTrials.gov/show/NCT00162513
182695182695A Novel Vaccine for the Treatment of MUC1-expressing Tumor MalignanciesWithdrawnNo Results AvailableMultiple Myeloma|TumorsBiological: Peptide Vaccine (MUC-1)https://ClinicalTrials.gov/show/NCT00162500
182696182696Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol InhalationRecruitingNo Results AvailableHyperkalemia|Chronic Renal FailureDrug: Albuterol (1,200 μg) through metered-dose inhalerhttps://ClinicalTrials.gov/show/NCT00162487
182697182697Determinants of Warfarin MetabolismRecruitingNo Results AvailableHealthyDrug: Warfarin|Drug: Phenytoinhttps://ClinicalTrials.gov/show/NCT00162474
182698182698Evaluation of CYP2C9 ActivityRecruitingNo Results AvailableHealthyDrug: Phenytoin single dose (300 mg)https://ClinicalTrials.gov/show/NCT00162461
182699182699A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or DefibrillatorsCompletedNo Results AvailableHeart DiseasesDrug: BMS-394136|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00162448
182700182700Genetic Determinants of Warfarin Anticoagulation EffectRecruitingNo Results AvailableVenous Thrombosis|Pulmonary Embolism|Atrial FibrillationDrug: Warfarinhttps://ClinicalTrials.gov/show/NCT00162435

* Görseller ve İçerik tekif hakkına sahip olabilir